You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial
|
|---|---|
| Published in |
Frontiers in Pharmacology, September 2021
|
| DOI | 10.3389/fphar.2021.683296 |
| Pubmed ID | |
| Authors |
Chang Chen, Yi Zhang, Jianying Huang, Ping Yin, Zhenshun Cheng, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Mengxin Lu, Yongwen Luo, Lingao Ju, Jingyi Zhang, Xinghuan Wang |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 9% |
| Switzerland | 1 | 9% |
| Chile | 1 | 9% |
| United States | 1 | 9% |
| Unknown | 7 | 64% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 91% |
| Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 87 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 13% |
| Student > Bachelor | 9 | 10% |
| Student > Ph. D. Student | 6 | 7% |
| Other | 5 | 6% |
| Researcher | 4 | 5% |
| Other | 9 | 10% |
| Unknown | 43 | 49% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 9% |
| Biochemistry, Genetics and Molecular Biology | 6 | 7% |
| Chemistry | 4 | 5% |
| Immunology and Microbiology | 3 | 3% |
| Other | 7 | 8% |
| Unknown | 46 | 53% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2021.
All research outputs
#4,982,100
of 24,827,122 outputs
Outputs from Frontiers in Pharmacology
#2,299
of 18,929 outputs
Outputs of similar age
#104,703
of 422,332 outputs
Outputs of similar age from Frontiers in Pharmacology
#103
of 975 outputs
Altmetric has tracked 24,827,122 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,929 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 422,332 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 975 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.